الصفحة الرئيسية>>10-PAHSA 13C4

10-PAHSA 13C4

رقم الكتالوجGC41870

10-PAHSA 13C4 is an isotopically enriched form of the polyunsaturated fatty acid 10-PASHA with carbon-13 incorporated at positions 1, 2, 3, and 4.

Products are for research use only. Not for human use. We do not sell to patients.

10-PAHSA 13C4 التركيب الكيميائي

الحجم السعر المخزون الكميّة
100μg
111٫00
متوفر
250μg
250٫00
متوفر
500μg
445٫00
متوفر
1mg
780٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

10-PAHSA 13C4 is an isotopically enriched form of the polyunsaturated fatty acid 10-PASHA with carbon-13 incorporated at positions 1, 2, 3, and 4. It is intended for use as an internal standard for the quantification of 10-PAHSA by GC- or LC-MS. 10-PAHSA is a newly identified endogenous lipid that belongs to a collection of branched fatty acid esters of hydroxy fatty acids (FAHFAs). It is a FAHFA in which palmitic acid is esterified to 10-hydroxy stearic acid. Among the FAHFA family members, PAHSAs are the most abundant in the adipose tissue of glucose tolerant AG4OX mice, which overexpress the Glut4 glucose transporter specifically in adipose tissue. As other FAHFAs improve glucose tolerance, stimulate insulin secretion, and have anti-inflammatory effects, 10-PAHSA may be a bioactive lipid with roles in metabolic syndrome and inflammation.

مراجعات

Review for 10-PAHSA 13C4

Average Rating: 5 ★★★★★ (Based on Reviews and 24 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 10-PAHSA 13C4

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.